Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Gilead Sciences Inc (GILD)

NASDAQ
Currency in USD
Disclaimer
65.42
+0.15(+0.23%)
Closed
After Hours
65.50+0.08(+0.12%)

GILD Comments

*G*Lead* U * Lead Me Down..52 week low.🤦‍♂️👎
LOL. How did you invent Remdesivir and crash into a 52-week low?
The stock is still very overvalued. Even P/E ratio should be at least 2x lower with this growth (look at J&J or Pfizer for comparison). If we see disappointing results next year, I expect the price to fluctuate in the $20-30 range.
Hard to value Gilead with just P/E. They've had too many acquisitions that are hard to value currently.
TRASH :) for ur fake report in med research
Guess Remdesivir didn't work after all
According to FDA and Europe Remdesivir does work. They made over 900million in profits beating estimates. They increased revenue by over 20%. I think the problem is O’Day buying up a bunch of companies with stockholder dollars putting the company in debt. Unfortunately that is something that is not easily predictable.
Im still holding for next earnings.
 Yes, I knew about this company because of Hep C cure. CEO made too many acquisitions at a premium. I think next earnings will be interesting.
O'day should resign with no mercy. It's unbelievable such a top tier biotech in bay area now deemed a trash by WS.
Buy.. this is at 52 week low
$51-$55 soon and then load! too early
sell and buy nio
what's going on
worst stock ever
worst
Tax season around the corner
what is that mean
mean $51-$55
$66 coming next week or two?
agree. next week people will find out vaccine doesn't work
They can keep this vacine hype going on forever. But they are going to eliminate this virus just like they eliminated the flu. Probably gild will go up before they report next earnings. Hospitalizations 106k today
What a shame! It's sinking like a rock... see ja $51....
I had great expectations with this stock, but right now it's just a big disillusion. Nevertheless I will hold my shares, don't want to sell with losses. In a year or two it will go up, I hope. I don't buy any more, though.
at least it gives a good dividend
I am in since 2017, Pipeline is amazing HODL
 Think pipeline is decent, acquisition have had few flops but they can pay off in the future.
Needs to get above $61.50.
This stock gonna be great for long term investor. I have bougt extra 300 shares.
agree
They have a lot of products in pippline. If you dont buy in the dip, you are gonna regret💪
Looks like engolfing candle on the daily chart, i think a great stock for the next 2-3 years.
Why the stock fall?
BCS is not worth that price,I'm happy I sold it and bought NIO, COME ALSO
don't be blind, take profit and come to nio
Analyst they gain a lot of money out of delivering false news regarding this share
so pity guys u spend money for company like this
https://www.dailysignal.com/2020/11/02/hunter-biden-emails-texts-raise-questions-that-need-answers/
I wander how much $$$ fraud Fauci cashed out on this stock.
come to NIO better than wait for nothing here
Why is going up?
Because is not going down.
Hoping after the election when markets settle down, even though gilead's remdesivir isn't a vaccine, it will still be bought up and used widely. We keep learning more about covid every day. I estimate it will go back up to around $70 by december maybe more if government starts buying it up.
...
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.